Astragaloside in cancer chemoprevention and therapy

作     者：Yaning Wang Zhuo Zhang Zhaohua Cheng Wei Xie Hanjiao Qin Jiyao Sheng 

作者机构：Department of Hepatobiliary and Pancreatic SurgerySecond Hospital of Jilin UniversityChangchunJilin 130041China Department of OrthopedicsChina-Japan Union Hospital of Jilin UniversityChangchunJilin 13033China Department of OphthalmologySecond Hospital of Jilin UniversityChangchunJilin 130041China Department of RadiotherapySecond Hospital of Jilin UniversityChangchunJilin 130041China 

出 版 物：《Chinese Medical Journal》 (中华医学杂志（英文版）)

年 卷 期：2023年第136卷第10期

页      面：1144-1154页

核心收录：

学科分类：1006[医学-中西医结合] 100602[医学-中西医结合临床] 10[医学] 

基　　金：Natural Science Foundation of China(Nos.81902484,82002809) China Postdoctoral Science Foundation(No.2020M670864) Jilin Province young health scientist training program(No.2020Q017) Medical and Health Talents Project of Jilin Province(Nos.2020SCZT039,2020SCZT097) Youth Support Project of Jilin Association for Science and Technology(No.202028) Jilin Province Science and Technology Development Plan(No.20210204028YY) 

主　　题：Astragaloside Carcinoma Chemoprevention Anti-tumor Tumor recurrence 

摘      要：Tumor chemoprevention and treatment are two approaches aimed at improving the survival of patients with *** ideal anti-tumor drug is that which not only kills tumor cells but also alleviates tumor-causing risk factors,such as precancerous lesions,and prevents tumor *** herbal monomers are considered to be ideal treatment agents due to their multi-target *** has been shown to possess tumor chemoprevention,direct anti-tumor,and chemotherapeutic drug sensitization *** this paper,we review the effects of astragaloside on tumor prevention and treatment and provide directions for further research.